Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.
Year: 2009
Type: article
Source: PubMed
Institutions: University of Copenhagen, Amager Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2163293377
